课题基金 / 基金详情

IDENTIFICATION OF VIABLE MYOCARDIUM IN LEFT VENTRICULAR DYSFUNCTION

IDENTIFICATION OF VIABLE MYOCARDIUM IN LEFT VENTRICULAR DYSFUNCTION
左心室功能障碍中存活心肌的鉴定
批准号:
3757707
负责人:
V DILSIZIAN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

V DILSIZIAN的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Thallium reinjection protocols have the disadvantage of requiring 3 sets of images, after exercise, 3-4 hr redistribution, and reinjection. An attractive alternative is to reinject 1 mCi of thallium immediately after the exercise images and imaging 3-4 hrs later, yielding a modified redistribution image representing redistribution of both the initial and the reinjected thallium doses. To determine the adequacy of exercise and modified redistribution images in identifying reversible defects, we studied 32 patients (ages 40 to 76; 23 men and 9 women) with chronic coronary artery disease by exercise thallium tomography. In addition to exercise and modified redistribution images, we also reinjected another 1 mCi of thallium after the modified redistribution image at 3-4 hrs. The exercise, modified redistribution, and 3-4 hr reinjection images were then normalized and analyzed quantitatively. Of the 81 abnormal regions on the exercise images, 30 (37%) were irreversible on modified redistribution images. However, 7 (23%) of these irreversible defects reversed after 3-4 hr reinjection, with mean thallium activities increasing from 54+5 (exercise) and 57+4 (modified redistribution) to 69+7 (reinjection, p<0.001). Only 4 of 51 reversible regions on modified redistribution appeared irreversible after 3-4 hr reinjection. All regions with reversibility only on 3-4 hr reinjection images were supplied by critically stenosed coronary arteries. These data suggest that modified redistribution imaging will overestimate myocardial fibrosis in roughly 1/4 of irreversible defects and that a 3-4 hr delay is necessary for accurate determination of myocardial ischemia and viability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TOMOGRAPHIC RADIONUCLIDE ANGIOGRAPHY
ASSESSMENT OF MYOCARDIAL VIABILITY WITH TECHNETIUM-99M SESTAMIBI
IDENTIFICATION OF VIABLE MYOCARDIUM IN LEFT VENTRICULAR DYSFUNCTION
COMPARISON OF SESTAMIBI DEFECTS WITH KNOWN INDICES OF ADVERSE PROGNOSIS